BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Impact Events

More
Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
4/15/21 CellTrans Donislecel for Diabetes Mellitus, Type I Subscribers Only Subscribers Only Subscribers Only
4/14/21 GlaxoSmithKline (GSK) Feladilimab for Head and Neck Cancer Subscribers Only Subscribers Only Subscribers Only
4/13/21 CellTrans Donislecel for Diabetes Mellitus, Type I Subscribers Only Subscribers Only Subscribers Only
4/13/21 Rigel Pharmaceuticals (RIGL) Tavalisse for COVID-19 Treatment Subscribers Only Subscribers Only Subscribers Only
4/13/21 Gilead Sciences (GILD) Trodelvy for Bladder Cancer Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected
Date Range
Lead
Company
Drug Expected
Catalyst
08/16/19 Subscribers Only Subscribers Only Partnership - Acquisition Completion
04/16/21 Subscribers Only Subscribers Only Regulatory - Supplemental Filing (Europe)
04/17/21 Subscribers Only Subscribers Only Trial Data - Updated Results
04/18/21 Subscribers Only Subscribers Only Trial Data - Updated Results
04/19/21 Subscribers Only Subscribers Only Trial Data - Updated Results
Back to the top Back to the top